We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Smith & Nephew has agreed to acquire ArthroCare for $1.5 billion, a move that could spur other orthopedic acquisitions by major players, an analyst says. Read More
Four employees of a medical device company who pleaded guilty to withholding side effect information in an IDE got off relatively easy in their settlement agreements, attorneys say. Read More
An HHS final rule permitting patients direct access to their laboratory test reports will not have many direct consequences for Dx makers, but could result in more patients blaming manufacturers for incorrect test results, an industry expert says. Read More
St. Jude’s Sylmar, Calif., plant, which makes most of its CRM products, should soon emerge from an FDA warning letter, CEO Dan Starks said on the company’s earnings call last month. Read More
A recent appeals court hearing on the Securities and Exchange Commission’s conflict minerals disclosure rule provided no immediate relief for manufacturers — though the line of questioning suggested some judges were sympathetic to industry’s free speech argument against the rule. Read More